Targeted Medical Pharma Exhibits at the 2011 JFPS in Dallas, Texas
Los Angeles, CA, November 14, 2011
Targeted Medical Pharma Inc. which develops and sells medical food products through its subsidiary Physician Therapeutics, exhibited product information and technology related to its medical foods addressing pain management and sleep disorders related to Post Traumatic Stress Disorder to over 2000 active and retired United States Military pharmacists, service men and women at the Joint Continue →
Targeted Medical Pharma Awarded $733,429.00 in Qualifying New Therapeutic Discovery Grants
Grants Cover Theramine® , Sentra PM®, Sentra AM® and GABAdone®
Los Angeles, CA, Nov. 1, 2010 /Targeted Medical Pharma Inc. a Specialty Pharma company developing proprietary medical food products distributed through subsidiary Physician Therapeutics announced it has been awarded $733,429.00 in government grants. Under the recently enacted Patient Protection and Affordable Care Act, cash grants Continue →
Double-Blind Clinical Trial of Theramine Published in the American Journal of Therapeutics
Read article “Double-Blind Clinical Trial of Theramine Published in the American Journal of Therapeutics” here.
Physician Therapeutics Clinical Trial Update
In January of 2009 Physician Therapeutics, a wholly owned subsidiary of Targeted Medical Pharma Inc., initiated A Double Blind randomized controlled trial of single dose Naproxen and an amino acid Medical Food Theramine for the treatment of low back pain. Using 10 national sites over a 28 day period, this study consisted of 127 patients Continue →